Literature DB >> 10330339

Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder.

D E Sleat1, R M Gin, I Sohar, K Wisniewski, S Sklower-Brooks, R K Pullarkat, D N Palmer, T J Lerner, R M Boustany, P Uldall, A N Siakotos, R J Donnelly, P Lobel.   

Abstract

The late-infantile form of neuronal ceroid lipofuscinosis (LINCL) is a progressive and ultimately fatal neurodegenerative disease of childhood. The defective gene in this hereditary disorder, CLN2, encodes a recently identified lysosomal pepstatin-insensitive acid protease. To better understand the molecular pathology of LINCL, we conducted a genetic survey of CLN2 in 74 LINCL families. In 14 patients, CLN2 protease activities were normal and no mutations were identified, suggesting other forms of NCL. Both pathogenic alleles were identified in 57 of the other 60 LINCL families studied. In total, 24 mutations were associated with LINCL, comprising six splice-junction mutations, 11 missense mutations, 3 nonsense mutations, 3 small deletions, and 1 single-nucleotide insertion. Two mutations were particularly common: an intronic G-->C transversion in the invariant AG of a 3' splice junction, found in 38 of 115 alleles, and a C-->T transition in 32 of 115 alleles, which prematurely terminates translation at amino acid 208 of 563. An Arg-->His substitution was identified, which was associated with a late age at onset and protracted clinical phenotype, in a number of other patients originally diagnosed with juvenile NCL.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330339      PMCID: PMC1377895          DOI: 10.1086/302427

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

1.  Chromosomal localization of two genes underlying late-infantile neuronal ceroid lipofuscinosis.

Authors:  J L Haines; R M Boustany; J Alroy; K J Auger; K S Shook; H Terwedow; T J Lerner
Journal:  Neurogenetics       Date:  1998-03       Impact factor: 2.660

Review 2.  Human forms of neuronal ceroid-lipofuscinosis (Batten disease): consensus on diagnostic criteria, Hamburg 1992.

Authors:  A Kohlschütter; R M Gardiner; H H Goebel
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

3.  Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I.

Authors:  D J Vines; M J Warburton
Journal:  FEBS Lett       Date:  1999-01-25       Impact factor: 4.124

4.  An assay to detect glycoproteins that contain mannose 6-phosphate.

Authors:  K J Valenzano; L M Kallay; P Lobel
Journal:  Anal Biochem       Date:  1993-02-15       Impact factor: 3.365

5.  Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease).

Authors:  D N Palmer; I M Fearnley; J E Walker; N A Hall; B D Lake; L S Wolfe; M Haltia; R D Martinus; R D Jolly
Journal:  Am J Med Genet       Date:  1992-02-15

6.  Two common mutations in the CLN2 gene underlie late infantile neuronal ceroid lipofuscinosis.

Authors:  N Zhong; K E Wisniewski; J Hartikainen; W Ju; D N Moroziewicz; L McLendon; S S Sklower Brooks; W T Brown
Journal:  Clin Genet       Date:  1998-09       Impact factor: 4.438

7.  Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man.

Authors:  A D'Azzo; A Hoogeveen; A J Reuser; D Robinson; H Galjaard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

8.  Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis.

Authors:  C G Liu; D E Sleat; R J Donnelly; P Lobel
Journal:  Genomics       Date:  1998-06-01       Impact factor: 5.736

9.  CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis.

Authors:  M Savukoski; T Klockars; V Holmberg; P Santavuori; E S Lander; L Peltonen
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

10.  Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S.

Authors:  A K Das; C H Becerra; W Yi; J Y Lu; A N Siakotos; K E Wisniewski; S L Hofmann
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

View more
  42 in total

Review 1.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

2.  The human urine mannose 6-phosphate glycoproteome.

Authors:  David E Sleat; Haiyan Zheng; Peter Lobel
Journal:  Biochim Biophys Acta       Date:  2006-12-20

3.  A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis.

Authors:  Feng Yu; Xiao-Min Liu; Yin-He Chen; Sheng-Quan Zhang; Kai Wang
Journal:  Neurol Sci       Date:  2015-06-02       Impact factor: 3.307

Review 4.  Astrocytes and lysosomal storage diseases.

Authors:  K V Rama Rao; T Kielian
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

5.  Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2,2)-dimethyl butyrate, a brain endogenous ligand of PPARα: Implications for late-infantile Batten disease therapy.

Authors:  Sudipta Chakrabarti; Sujyoti Chandra; Avik Roy; Sridevi Dasarathi; Madhuchhanda Kundu; Kalipada Pahan
Journal:  Neurobiol Dis       Date:  2019-03-28       Impact factor: 5.996

6.  Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis.

Authors:  L Lin; P Lobel
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

7.  A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration.

Authors:  David E Sleat; Jennifer A Wiseman; Mukarram El-Banna; Kwi-Hye Kim; Qinwen Mao; Sandy Price; Shannon L Macauley; Richard L Sidman; Michael M Shen; Qi Zhao; Marco A Passini; Beverly L Davidson; Gregory R Stewart; Peter Lobel
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

8.  The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis.

Authors:  Jake N Miller; Chun-Hung Chan; David A Pearce
Journal:  Hum Mol Genet       Date:  2013-03-28       Impact factor: 6.150

9.  Residual levels of tripeptidyl-peptidase I activity dramatically ameliorate disease in late-infantile neuronal ceroid lipofuscinosis.

Authors:  David E Sleat; Mukarram El-Banna; Istvan Sohar; Kwi-Hye Kim; Kostantin Dobrenis; Steven U Walkley; Peter Lobel
Journal:  Mol Genet Metab       Date:  2008-03-17       Impact factor: 4.797

10.  Assessment of disease severity in late infantile neuronal ceroid lipofuscinosis using multiparametric MR imaging.

Authors:  J P Dyke; D Sondhi; H U Voss; D C Shungu; X Mao; K Yohay; S Worgall; N R Hackett; C Hollmann; M E Yeotsas; A L Jeong; B Van de Graaf; I Cao; S M Kaminsky; L A Heier; K D Rudser; M M Souweidane; M G Kaplitt; B Kosofsky; R G Crystal; D Ballon
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-04       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.